Palisade Bio (PALI)

Palisade Bio (PALI) Financial Statements


Palisade Bio Financial Overview

Palisade Bio's market cap is currently ―. The company's EPS TTM is $-19.063; its P/E ratio is -0.10; Palisade Bio is scheduled to report earnings on May 12, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -3.99M$ -2.34M$ -4.20M$ 1.08M$ 8.11M
EBITDA$ -3.99M$ -2.34M$ -4.20M$ 1.08M$ 8.11M
Net Income Common Stockholders$ -3.99M$ -2.34M$ -4.21M$ 1.07M$ 5.12M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 13.98M$ 4.98M$ 6.64M$ 10.49M$ 14.10M
Total Assets$ 16.27M$ 7.81M$ 8.35M$ 12.51M$ 16.27M
Total Debt$ 692.00K$ 975.00K$ 65.00K$ 199.00K$ 726.00K
Net Debt$ -13.29M$ -4.00M$ -6.58M$ -10.30M$ -13.38M
Total Liabilities$ 3.84M$ 3.60M$ 3.56M$ 5.15M$ 12.35M
Stockholders Equity$ 12.43M$ 4.21M$ 4.79M$ 7.37M$ 3.92M
Cash Flow-
Free Cash Flow$ -3.04M$ -3.25M$ -3.76M$ -3.06M$ -2.75M
Operating Cash Flow$ -3.04M$ -3.25M$ -3.76M$ -3.06M$ -2.75M
Investing Cash Flow$ 0.00--$ 0.00$ -348.00K
Financing Cash Flow$ 12.04M$ 1.59M$ -87.00K$ -554.00K$ 4.54M
Currency in USD

Palisade Bio Earnings and Revenue History

Palisade Bio Debt to Assets

Palisade Bio Cash Flow

Palisade Bio Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis